TBRG

MKT CAP:$387M

TruBridge, Inc.

Market Cap

$387M

Healthcare·Medical - Healthcare Information Services·🇺🇸 United States·NASDAQ

Healthcare·Medical·🇺🇸·NASDAQ

Stock Price

$25.76+$4.86 (+23.25%)

Apr 23, 2026

Company Details

TruBridge, Inc. provides healthcare solutions and services for community hospitals, clinics, and other healthcare systems in the United States and internationally. The company operates in three segments: Revenue Cycle Management (RCM), Elec...

CEO

Christopher L. Fowler

IPO Date

May 21, 2002

Website

www.trubridge.com

Key Metrics TTM

Revenue

$350M

+3.3% YoY

Net Income

$6M

EPS (Diluted)

$0.18

Free Cash Flow

$29M

Revenue / Share

$24.17

Gross Margin

53.2%

Operating Margin

7.2%

Net Margin

1.6%

FCF Margin

8.4%

P/S

1.1x

P/E

69.4x

Earnings Reports

Q4 2025

May 6, 2026

PENDING

FY 2025

Mar 30, 2026

$347M+1.2%EPS $0.29

Q3 2025

Nov 7, 2025

$86MEPS $0.37

Q2 2025

Aug 8, 2025

$86M+0.2%EPS $0.17

Q1 2025

May 9, 2025

$87MEPS $0.03

Revenue & Profitability

Quarter	Revenue	Gross Profit	Operating Income
Q2 21	$69M	$34M	$8M
Q3 21	$70M	$35M	$5M
Q1 22	$78M	$41M	$9M
Q2 22	$83M	$41M	$5M
Q3 22	$83M	$40M	$5M
Q4 22	$83M	$37M	$4M
Q1 23	$86M	$42M	$6M
Q2 23	$85M	$40M	-$2M
Q3 23	$83M	$39M	-$5M
Q4 23	$86M	$42M	-$42M
Q2 24	$86M	$42M	-$2M
Q4 24	$91M	$50M	$9M
Q1 25	$87M	$48M	$8M
Q2 25	$86M	$44M	$4M
Q3 25	$86M	$44M	$4M

Valuation

Quarter	P/S	P/E
Q2 21	—	—
Q3 21	—	—
Q1 22	—	—
Q2 22	1.6x	23.7x
Q3 22	1.3x	25.2x
Q4 22	1.2x	24.7x
Q1 23	1.3x	39.5x
Q2 23	1.1x	72.9x
Q3 23	0.7x	—
Q4 23	0.4x	—
Q2 24	0.4x	—
Q4 24	0.8x	—
Q1 25	1.1x	—
Q2 25	1.0x	—
Q3 25	0.8x	53.0x

Operating Cash Flow

Quarter	Operating CF	Free CF
Q2 21	$19M	$19M
Q3 21	$1M	-$1M
Q1 22	$12M	$12M
Q2 22	$7M	$7M
Q3 22	$11M	$5M
Q4 22	$2M	-$2M
Q1 23	$9M	$3M
Q2 23	$717.0K	-$5M
Q3 23	$3M	$3M
Q4 23	-$12M	-$17M
Q2 24	$14M	$9M
Q4 24	$10M	$6M
Q1 25	$6M	$1M
Q2 25	$9M	$8M
Q3 25	$14M	$14M

Capital Expenditures

Quarter	CapEx
Q2 21	$192.0K
Q3 21	$3M
Q1 22	$27.0K
Q2 22	$61.0K
Q3 22	$6M
Q4 22	$5M
Q1 23	$6M
Q2 23	$6M
Q3 23	$260.0K
Q4 23	$5M
Q2 24	$5M
Q4 24	$4M
Q1 25	$4M
Q2 25	$544.0K
Q3 25	$63.0K

CapEx

OpEx vs Revenue Growth (YoY)

Quarter	Revenue Growth	OpEx Growth
Q3 22	+20.9%	+28.1%
Q4 22	+18.7%	+20.4%
Q1 23	+10.7%	+16.0%
Q2 23	+2.3%	+10.7%
Q3 23	-0.1%	+12.9%
Q4 23	+3.2%	+61.7%
Q2 24	-0.7%	+9.8%
Q4 24	+7.3%	-5.6%
Q1 25	+5.4%	-10.1%
Q2 25	-0.2%	-35.7%
Q3 25	+0.6%	-6.5%

Stock-Based Compensation

Quarter	SBC ($)	% of Revenue
Q2 21	$1M	2.1%
Q3 21	$2M	2.4%
Q1 22	$2M	2.2%
Q2 22	$2M	2.1%
Q3 22	$2M	2.3%
Q4 22	-$111.0K	-0.1%
Q1 23	$1M	1.4%
Q2 23	-$123.0K	-0.1%
Q3 23	$1M	1.3%
Q4 23	$1M	1.3%
Q2 24	$2M	1.8%
Q4 24	$2M	2.0%
Q1 25	$1M	1.4%
Q2 25	$2M	2.4%
Q3 25	$2M	2.1%

OpEx Breakdown

Quarter	R&D	G&A	S&M
Q2 21	$6M	$11M	$5M
Q3 21	$8M	$14M	$5M
Q1 22	$8M	$13M	$7M
Q2 22	$8M	$15M	$8M
Q3 22	$8M	$13M	$7M
Q4 22	$9M	$15M	$5M
Q1 23	$8M	$14M	$7M
Q2 23	$9M	$19M	$8M
Q3 23	$10M	$21M	$7M
Q4 23	$10M	$22M	$6M
Q2 24	$8M	$19M	$8M
Q4 24	$8M	$19M	$7M
Q1 25	$8M	$19M	$5M
Q2 25	$8M	$18M	$8M
Q3 25	$16M	$19M	$6M

War Chest

Quarter	Cash	Short-term Investments	Total
Q1 22	$16M	$0	$16M
Q2 22	$15M	$0	$15M
Q3 22	$16M	$0	$16M
Q4 22	$7M	$0	$7M
Q1 23	$7M	$0	$7M
Q2 23	$7M	$0	$7M
Q3 23	$1M	$0	$1M
Q4 23	$4M	$0	$4M
Q1 24	$4M	$0	$4M
Q2 24	$8M	$0	$8M
Q3 24	$9M	$0	$9M
Q4 24	$12M	$0	$12M
Q1 25	$10M	$0	$10M
Q2 25	$12M	$0	$12M
Q3 25	$19.9K	$0	$19.9K
Q4 25	$25M	$0	$25M

Shares Outstanding

Quarter	Shares (Diluted)	QoQ Change	YoY Change
Q2 21	14M	—	—
Q3 21	14M	0.0%	—
Q1 22	14M	+0.3%	—
Q2 22	14M	+0.6%	—
Q3 22	14M	-0.7%	+0.2%
Q4 22	14M	-1.1%	-0.9%
Q1 23	14M	-0.5%	-1.7%
Q2 23	14M	+0.5%	-1.9%
Q3 23	14M	+0.0%	-1.1%
Q4 23	14M	0.0%	-0.0%
Q2 24	14M	+0.8%	+1.3%
Q4 24	14M	-0.1%	+0.7%
Q1 25	14M	+0.5%	+1.2%
Q2 25	15M	+1.1%	+2.2%
Q3 25	14M	-0.3%	+1.1%

Shares Outstanding

Revenue Per Employee

Period	Revenue/Employee	Employees
Q2 21	—	—
Q3 21	—	—
Q1 22	—	—
Q2 22	—	—
Q3 22	—	—
Q4 22	—	—
Q1 23	—	—
Q2 23	—	—
Q3 23	—	—
Q4 23	—	—
Q2 24	—	—
Q4 24	$60.6K	2K
Q1 25	$58.1K	2K
Q2 25	$57.2K	2K
Q3 25	$57.4K	2K

Revenue / Employee